¼¼°èÀÇ ¹ÙÀÌ¿ÀÇØÅ· ½ÃÀå
Biohacking
»óǰÄÚµå : 1777853
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 281 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,183,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,550,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¹ÙÀÌ¿ÀÇØÅ· ½ÃÀåÀº 2030³â±îÁö 648¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 236¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¹ÙÀÌ¿ÀÇØÅ· ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 18.4%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 648¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹ÙÀÌ¿ÀÇØÅ·º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¿þ¾î·¯ºíÀº CAGR 22.5%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 100¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹ÙÀÌ¿ÀÇØÅ· ÀÓÇöõÆ® ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 19.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 64¾ï ´Þ·¯, Áß±¹Àº CAGR24.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¹ÙÀÌ¿ÀÇØÅ· ½ÃÀåÀº 2024³â¿¡ 64¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 148¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 24.6%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 13.3%¿Í 16.7%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 14.7%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¹ÙÀÌ¿ÀÇØÅ· ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¹ÙÀÌ¿ÀÇØÅ·ÀÌ ¼ÒºñÀÚ¿Í Á¶»ç°üµéÀÇ ÁöÁö¸¦ ¹Þ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

¹ÙÀÌ¿ÀÇØÅ·Àº Àΰ£ÀÇ ¼º´ÉÀ» ÃÖÀûÈ­Çϱâ À§ÇØ »ý¹°Çаú ±â¼úÀ» À¶ÇÕÇÑ È¹±âÀûÀÎ ¿îµ¿À¸·Î, ±× ÀαⰡ ±Þ¼Óµµ·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °³Àΰú ±â¾÷ ¸ðµÎ ¿þ¾î·¯ºí ±â¼ú, ¿µ¾ç º¸ÃæÁ¦, À¯ÀüÀÚ ÀçÁ¶ÇÕ, ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ÃÖÀûÈ­ µî ´Ù¾çÇÑ ¹ÙÀÌ¿ÀÇØÅ· ±â¼úÀ» ÅëÇØ ½ÅüÀû, ÀÎÁöÀû ±â´ÉÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â ¹æ¹ýÀ» ¸ð»öÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °ü½É Áõ°¡´Â ±âÁ¸ ÀǷḦ ³Ñ¾î °³ÀÎÈ­µÈ °Ç°­ ¹× À£´Ï½º ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÑ ¹Ù°¡ Å®´Ï´Ù. ¹ÙÀÌ¿ÀÇØÅ·ÀÇ ºÎ»óÀº ±¤¹üÀ§ÇÑ À£ºù ¹× Àå¼ö Æ®·»µå¿Í ¹ÐÁ¢ÇÑ °ü·ÃÀÌ ÀÖÀ¸¸ç, ¼ÒºñÀÚµéÀº À£ºù, »ý»ê¼º ¹× Àü¹ÝÀûÀÎ ¼ö¸íÀ» Çâ»ó½Ã۱â À§ÇÑ Àû±ØÀûÀÎ Á¶Ä¡¸¦ ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÇØÅ· Á¦Ç° ¹× ¼­ºñ½º¸¦ °³¹ßÇÏ´Â ±â¾÷µéÀº °úÇÐ ¿¬±¸¿Í ½ÇÁ¦ ¿ëµµÀÇ ÅëÇÕ¿¡ ÁßÁ¡À» µÎ¾î »ç¿ëÀÚ°¡ »ýü Á¤º¸¸¦ ÃßÀûÇϰí, ½Ä´ÜÀ» ÃÖÀûÈ­Çϰí, ½Å°æ ÀÚ±Ø ¹× ¹ÙÀÌ¿À Çǵå¹é ±â¼úÀ» ÅëÇØ ÀÎÁö ±â´ÉÀ» Çâ»ó½Ãų ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿Í µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ ¹ßÀüÀ¸·Î ¹ÙÀÌ¿ÀÇØÅ·Àº Æ´»õ °ü½É»ç¿¡¼­ Å« ¼ºÀå ÀáÀç·ÂÀ» °¡Áø ÁÖ·ù ½ÃÀåÀ¸·Î À̵¿Çϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¹ÙÀÌ¿ÀÇØÅ· ½ÃÀåÀ» ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

÷´Ü ±â¼úÀÇ ÅëÇÕÀº ¹ÙÀÌ¿ÀÇØÅ· ½ÃÀå È®´ë¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. »ýü ½ÅÈ£, ¼ö¸é ÆÐÅÏ, Æ÷µµ´ç ¼öÄ¡¸¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÏ´Â ¿þ¾î·¯ºí ±â±â°¡ ³Î¸® º¸±ÞµÇ¸é¼­ °³ÀÎÀÌ µ¥ÀÌÅÍ ±â¹Ý ÅëÂû·ÂÀ¸·Î °Ç°­À» °ü¸®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, CRISPR°ú °°Àº À¯ÀüÀÚ ÆíÁý ±â¼úÀÇ ºñ¾àÀûÀÎ ¹ßÀüÀ¸·Î ¹ÙÀÌ¿À ÇØÄ¿µéÀÌ DNA¸¦ º¯ÇüÇÏ´Â ½ÇÇèÀ» ÇÒ ¼ö ÀÖ°Ô µÇ¸é¼­ Áúº´ ¿¹¹æ°ú Àå¼ö ÁõÁøÀ» À§ÇÑ »õ·Î¿î °¡´É¼ºÀÌ ¿­¸®°í ÀÖ½À´Ï´Ù. ½ÃÀåÀ» Ȱ¼ºÈ­Çϰí ÀÖ´Â ¶Ç ´Ù¸¥ Å« ±â¼úÀû Áøº¸´Â ÀÎÁö ´É·Â, ±â¾ï·Â, Á¤½Å ¼±¸íµµ¸¦ Çâ»ó½Ã۱â À§ÇØ °í¾ÈµÈ ÇâÁ¤½Å¼º ¾à¹°, ½º¸¶Æ® ¾à¹°, »ýü°øÇÐ º¸Á¶Á¦ÀÇ °³¹ßÀÔ´Ï´Ù. AI¸¦ Ȱ¿ëÇÑ °Ç°­ ºÐ¼® Ç÷§Æûµµ À¯ÀüÀÚ ¹× ´ë»ç µ¥ÀÌÅ͸¦ Ȱ¿ëÇÏ¿© °³Àο¡°Ô ¸Â´Â °Ç°­¹ýÀ» ¸¸µé°í, °³ÀÎÀÇ ¹ÙÀÌ¿ÀÇØÅ· Á¢±Ù¹ýÀ» ¸ÂÃãÈ­ÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å°æ°úÇаú ¹ÙÀÌ¿ÀÇØÅ·ÀÇ À¶ÇÕÀ¸·Î ³ú-ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º(BCI)°¡ ºÎ»óÇϸ鼭 Àΰ£ÀÇ ³ú¿Í µðÁöÅÐ ±â±âÀÇ Á÷Á¢ÀûÀÎ »óÈ£ ÀÛ¿ëÀ» °¡´ÉÇÏ°Ô ÇÏ¿© ÀÎÁö ±â´É°ú ½Å°æ °¡¼Ò¼ºÀÌ ÀÌÀü°ú´Â ´Ù¸¥ ¹æ½ÄÀ¸·Î °­È­µÇ°í ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿ÀÇØÅ·ÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ½ÃÀå µ¿ÇâÀº?

Àå¼ö¿Í Àΰ£ °­È­¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½É Áõ°¡´Â ¹ÙÀÌ¿ÀÇØÅ· ½ÃÀåÀ» ÁÖµµÇÏ´Â °¡Àå Áß¿äÇÑ Æ®·»µå Áß ÇϳªÀÔ´Ï´Ù. »ç¶÷µéÀº °úÇÐÀû ±Ù°Å°¡ ÀÖ´Â °³ÀÔÀ» ÅëÇØ ¼ö¸íÀ» ¿¬ÀåÇÏ°í »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â ¹æ¹ýÀ» Á¡Á¡ ´õ ¸¹ÀÌ Ã£°í ÀÖ½À´Ï´Ù. ±× °á°ú, ¹ÙÀÌ¿ÀÇØÅ· ±â¾÷µéÀº ¿¬±¸¿Í Á¦Ç° °³¹ß¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖÀ¸¸ç, ½ÅüÀû, Á¤½ÅÀû ¼º´ÉÀ» Çâ»ó½ÃŰ´Â ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ½ÃÀåÀ» Çü¼ºÇÏ´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ Æ®·»µå´Â DIY ¹ÙÀÌ¿ÀÇØÅ·ÀÇ ¼ö¿ë È®´ëÀÔ´Ï´Ù. Ä¿¹Â´ÏƼ ÁÖµµÀÇ ¹ÙÀÌ¿ÀÇØÅ· ¿îµ¿, ¿ÀǼҽº »ý¹°ÇÐ ½ÇÇè½Ç, °¡Á¤¿ë À¯ÀüÀÚ °Ë»ç ŰƮ µîÀÇ µîÀåÀ¸·Î ¹ÙÀÌ¿ÀÇØÅ·Àº ´õ ¸¹Àº »ç¶÷µé¿¡°Ô Ä£¼÷ÇØÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â¾÷ÀÇ À£´Ï½º ÇÁ·Î±×·¥Àº Á÷¿øµéÀÇ »ý»ê¼º°ú Çູ°¨À» ³ôÀ̱â À§ÇØ ½ÅÁø´ë»ç ÃßÀû, ½Å°æ °­È­ ÇÁ·Î±×·¥ µî ¹ÙÀÌ¿ÀÇØÅ·ÀÇ Á¶»ç ±â¹ýÀ» µµÀÔÇϱ⠽ÃÀÛÇß½À´Ï´Ù. ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ ¹ÙÀÌ¿ÀÇØÅ·ÀÇ Çõ½Å¿¡ ´ëÀÀÇÒ ¼ö ÀÖµµ·Ï ÁøÈ­ÇÔ¿¡ µû¶ó, ´õ ¸¹Àº ¼ÒºñÀÚµéÀÌ ÀÏ»ó »ýȰÀÇ ÀϺηΠÀÌ·¯ÇÑ ±â¼úÀ» äÅÃÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹ÙÀÌ¿ÀÇØÅ· ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº?

¹ÙÀÌ¿ÀÇØÅ· ½ÃÀåÀÇ ¼ºÀåÀº °³ÀÎÈ­µÈ ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¿þ¾î·¯ºí ±â¼úÀÇ ¹ßÀü, ¼º´É Çâ»ó¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½É Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. µðÁöÅÐ Çコ Ç÷§Æû°ú ÀÚ°¡ ¸ð´ÏÅ͸µ ±â±âÀÇ º¸±ÞÀº °³ÀÎÀÇ »ýü ±â´ÉÀ» ½Ç½Ã°£À¸·Î ÃßÀûÇϰí ÃÖÀûÈ­ÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ý¸í°øÇÐ, À¯Àü°øÇÐ, AI¸¦ Ȱ¿ëÇÑ °Ç°­ ºÐ¼®ÀÇ ±Þ¼ÓÇÑ ¹ßÀüÀº ¹ÙÀÌ¿ÀÇØÅ·¿¡ Çõ¸íÀ» °¡Á®¿Ô°í, º¸´Ù Ä£¼÷Çϰí È¿°úÀûÀÎ ¹æ¹ýÀ¸·Î ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ¿¹¹æÀû °Ç°­°ü¸®¿Í Àå¼ö ÃÖÀûÈ­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ »ýü°øÇÐ ±â¹Ý º¸ÃæÁ¦ºÎÅÍ ½Å°æ Àڱرâ±îÁö ´Ù¾çÇÑ ¹ÙÀÌ¿ÀÇØÅ· Á¦Ç°¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿Í Àΰ£ Áõ°­ ±â¼úÀÇ ²÷ÀÓ¾ø´Â Çõ½ÅÀ¸·Î ¹ÙÀÌ¿ÀÇØÅ· ½ÃÀåÀº ºñ¾àÀûÀÎ ¼ºÀåÀ» ÀÌ·ç¸ç °³ÀÎÀÇ °Ç°­, ¼º´É, ¼ö¸íÀ» °ü¸®ÇÏ´Â ¹æ½ÄÀ» º¯È­½Ã۰í ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(¹ÙÀÌ¿ÀÇØÅ· ¿þ¾î·¯ºí, ¹ÙÀÌ¿ÀÇØÅ· ÀÓÇöõÆ®, À¯ÀüÀÚ ÀçÁ¶ÇÕ Å°Æ®, ½º¸¶Æ® µå·¯±×, ¹ÙÀÌ¿ÀÇØÅ· º¸ÃæÁ¦, ¹ÙÀÌ¿ÀÇØÅ· ¸ð¹ÙÀÏ ¾Û, ±âŸ Á¦Ç° À¯Çü), ¿ëµµ(Áø´Ü ¹× Ä¡·á, À¯ÀüÀÚ °øÇÐ, ¹ýÀÇÇÐ, ±âŸ), ÃÖÁ¾ ¿ëµµ(º´¿ø ¹× Ŭ¸®´Ð, Á¦¾à ±â¾÷ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷, ¹ýÀÇÇÐ ¿¬±¸¼Ò, ¿¬±¸ ¹× Çмú±â°ü)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Biohacking Market to Reach US$64.8 Billion by 2030

The global market for Biohacking estimated at US$23.6 Billion in the year 2024, is expected to reach US$64.8 Billion by 2030, growing at a CAGR of 18.4% over the analysis period 2024-2030. Biohacking Wearables, one of the segments analyzed in the report, is expected to record a 22.5% CAGR and reach US$10.0 Billion by the end of the analysis period. Growth in the Biohacking Implants segment is estimated at 19.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.4 Billion While China is Forecast to Grow at 24.6% CAGR

The Biohacking market in the U.S. is estimated at US$6.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$14.8 Billion by the year 2030 trailing a CAGR of 24.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.3% and 16.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.

Global Biohacking Market - Key Trends & Drivers Summarized

Why Is Biohacking Gaining Traction Among Consumers and Researchers?

Biohacking, a revolutionary movement that merges biology with technology to optimize human performance, is rapidly growing in popularity. Individuals and companies alike are exploring ways to enhance physical and cognitive functions using various biohacking techniques, ranging from wearable technology and nootropic supplements to genetic modifications and microbiome optimization. This surge in interest is largely driven by the increasing demand for personalized health and wellness solutions that go beyond conventional medicine. The rise of biohacking is closely tied to the broader wellness and longevity trends, where consumers are seeking proactive measures to enhance their well-being, productivity, and overall lifespan. Companies developing biohacking products and services are focusing on integrating scientific research with real-world applications, enabling users to track biometrics, optimize diets, and enhance cognitive functions through neurostimulation and biofeedback techniques. With advancements in biotechnology and digital health solutions, biohacking is transitioning from a niche interest to a mainstream market with significant growth potential.

How Are Technological Advancements Transforming the Biohacking Market?

The integration of cutting-edge technologies is playing a critical role in expanding the biohacking market. Wearable devices that monitor vital signs, sleep patterns, and glucose levels in real time are becoming widely accessible, empowering individuals to take control of their health with data-driven insights. Additionally, breakthroughs in gene editing technologies, such as CRISPR, are enabling biohackers to experiment with DNA modifications, opening new possibilities for disease prevention and longevity enhancement. Another major technological advancement fueling the market is the development of nootropics, smart drugs, and bioengineered supplements designed to improve cognitive performance, memory, and mental clarity. AI-driven health analytics platforms are also helping individuals customize their biohacking approaches, utilizing genetic and metabolic data to create personalized wellness regimens. Moreover, the convergence of neuroscience and biohacking has led to the rise of brain-computer interfaces (BCIs), allowing direct interaction between the human brain and digital devices, enhancing cognitive function and neuroplasticity in unprecedented ways.

What Market Trends Are Driving the Growth of Biohacking?

The growing consumer interest in longevity and human enhancement is one of the most significant trends driving the biohacking market. People are increasingly looking for ways to extend their lifespan and improve quality of life through scientifically backed interventions. As a result, biohacking companies are investing heavily in research and product development to offer solutions that enhance both physical and mental performance. Another key trend shaping the market is the increasing acceptance of DIY biohacking, where individuals experiment with self-improvement techniques outside traditional medical settings. The rise of community-driven biohacking movements, open-source biology labs, and at-home genetic testing kits is making biohacking more accessible to a wider audience. Furthermore, corporate wellness programs are beginning to incorporate biohacking methodologies, including metabolic tracking and neuroenhancement programs, to boost employee productivity and well-being. As regulatory frameworks evolve to accommodate biohacking innovations, more consumers are expected to adopt these techniques as part of their daily routines.

What Are the Key Growth Drivers for the Biohacking Market?

The growth in the Biohacking market is driven by several factors, including the rising demand for personalized healthcare solutions, advancements in wearable technology, and increasing consumer interest in performance enhancement. The proliferation of digital health platforms and self-monitoring devices is enabling individuals to track and optimize their biological functions in real time, fueling market expansion. Additionally, the rapid progress in biotechnology, genetic engineering, and AI-powered health analytics is revolutionizing biohacking, making it more accessible and effective. The growing awareness of preventive healthcare and longevity optimization is also propelling demand for biohacking products, ranging from bioengineered supplements to neurostimulation devices. With continuous innovations in personalized medicine and human augmentation technologies, the biohacking market is poised for exponential growth, transforming the way individuals manage their health, performance, and longevity.

SCOPE OF STUDY:

The report analyzes the Biohacking market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Biohacking Wearables, Biohacking Implants, Gene Modification Kits, Smart Drugs, Biohacking Supplements, Biohacking Mobile Apps, Other Product Types); Application (Diagnosis and Treatment Application, Genetic Engineering Application, Forensic Science Application, Other Applications); End-Use (Hospitals and Clinics End-Use, Pharmaceutical and Biotechnology Companies End-Use, Forensic Laboratories End-Use, Research and Academic Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â